Washington, DC -- January 21, 2010 -- The American Cancer Society Cancer Action Network (ACS CAN) today joined national groups representing patients, consumers, seniors and workers in urging Congress to move forward on comprehensive health care reform.
WASHINGTON, D.C. – January 12, 2010 – As Congress works to merge the House and Senate health care reform bills, the American Cancer Society Cancer Action Network (ACS CAN) has sent a letter to congressional leaders calling for the strongest final bill possible for patients.
WASHINGTON -- January 7, 2010 -- Three of the nation’s leading patient groups are calling on congressional leaders to ensure that final health care reform legislation promotes evidence-based workplace wellness programs and encourages financial incentives for healthy behaviors that are not tied to
WASHINGTON, D.C. – December 24, 2009 – “Cancer patients, survivors and their loved ones are one step closer to a remedy for our nation’s ‘sick care’ system after the Senate today passed comprehensive health reform legislation.
After months of negotiations and weeks of floor debate, the American Cancer Society Cancer Action Network (ACS CAN) is calling on senators to invoke cloture and pass health care reform legislation this year so that House and Senate conferees can begin working on a strong final product for patients.
ACS CAN volunteer Dan Brodrick traveled to Washington, D.C.
WASHINGTON, DC -- December 11, 2009 -- “People with cancer are very encouraged that their concerns have been heard about a provision currently in the Senate health care reform bill that could subject patients to a sudden termination of coverage for critical care.
WASHINGTON, DC -- December 3, 2009 -- "Cancer patients and survivors are opposing the amendment to health care reform legislation offered by Sen. Lisa Murkowski (R-AK) because it would not ensure no-cost preventive services for women.
Statement by American Cancer Society Cancer Action Network (ACS CAN) President Daniel E. Smith
WASHINGTON -- November 20, 2009 -- The announcement this week from a federal scientific panel that women aged 40-49 should not get routine annual mammograms emphasizes the need to improve the way scientific evidence is weighed and recommendations are determined.